AMALY — SHARIAH COMPLIANCE REPORT
==================================
Symbol: POAI
Report Date: 2026-04-01
Full Report: https://amaly.io/stock/POAI

EXECUTIVE SUMMARY
------------------
Compliance Status: NON_COMPLIANT
Quality Rating: BB
Description: Predictive Oncology Inc. (POAI) operates in the biotech sector focusing on AI-driven drug discovery, particularly for cancer treatments. The company's financial ratios show strong compliance with debt and liquidity thresholds across major Shariah standards, with impure income at 4.88% just below the 5% limit. Business activities are permissible under Islamic principles, with no non-compliant revenue sources identified. However, due to its small market capitalization and liquidity, POAI is not included in major Shariah indices. Overall, while financially compliant, the lack of index inclusion results in a non-compliant status, with a BB quality rating indicating solid fundamentals but limited validation.

Primary Compliance Concerns:
- Lack of inclusion in Shariah indices due to small market cap and liquidity requirements

Purification Requirement: 4.88%
Index Inclusion: Not included in any of the four major Shariah-compliant indices

KEY FINANCIAL METRICS
----------------------
Debt Ratio: 1.6%
Liquidity Ratio: 2.6%
Interest Income Ratio: 4.9%
Purification Required: 4.88%

INDEX INCLUSION STATUS
-----------------------
S&P Shariah: INCLUDED
MSCI Islamic: EXCLUDED
DJIM: EXCLUDED
FTSE Shariah: EXCLUDED
Total: 1 of 4
Last Verified: Unknown

REPORTING PERIOD
-----------------
Latest Annual Report: FY 2025
Latest Quarterly Data: Q4 2025
Trend Period: FY 2020 to FY 2025
Data Retrieved: 2026-02-27T12:00:00Z

---
Full interactive report: https://amaly.io/stock/POAI
Provided by Amaly (https://amaly.io) — Shariah Compliant Stock Screener
Disclaimer: This data is for informational purposes only and does not constitute financial or religious advice.